A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects

Status Completed

Clinical Trial Summary

This will be a randomized, open-label parallel design and single centre study conducted at the 1st hospital affiliated to Jilin University. Approximately 24 healthy Chinese volunteers, male and female will be recruited and divided into two equal groups (12 subjects per dose). The primary objective of this study is to evaluate the pharmacokinetic profile of lanifibranor after single dose and multiple doses 800 and 1200 mg in healthy adult Chinese subjects. The secondary objective is to evaluate the safety of lanifibranor after single dose and multiple doses 800 and 1200 mg in healthy adult Chinese subjects.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pharmacokinetic

Clinical Trial Details

NCT number	NCT06126562
Study type	Interventional
Source	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	October 31, 2023
Completion date	December 15, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04531150` - Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects	Phase 1
Completed	`NCT03437265` - A Pharmacokinetic Study of PLENVU® in Healthy Subjects	Phase 1
Completed	`NCT03979989` - Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)	Phase 1
Completed	`NCT00743912` - Open-Label Study to Evaluate the Effect of Rifaximin on Midazolam in Normal Healthy Volunteers	Phase 1
Not yet recruiting	`NCT05367011` - Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICU
Completed	`NCT00745264` - Multi-Centre, Open-Label, Two Segment, Study Comparing Plasma Pharmacokinetics of Ketoprofen in Diractin® Alone to Diractin® Applied Concomitant With Heat or Moderate Exercise	Phase 1
Completed	`NCT03344627` - Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients	N/A
Completed	`NCT01082796` - Cytochrome P450 2C19 Variant is Related to Pharmacokinetics of Glipizide Extended Release Tablet in Chinese Subjects	N/A
Terminated	`NCT02696954` - Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects	Phase 1/Phase 2
Recruiting	`NCT03714568` - Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants.	Phase 1
Recruiting	`NCT04080895` - Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects	Phase 1
Active, not recruiting	`NCT04735913` - Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults	Early Phase 1
Completed	`NCT03011996` - To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration	Phase 1
Completed	`NCT00681395` - Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium	Phase 1
Completed	`NCT04617509` - A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248	Phase 1
Terminated	`NCT03059511` - Pharmacokinetics of Nalbuphine After Intravenous and Intranasal Administration in Infants	Phase 1
Withdrawn	`NCT05938608` - A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body	Phase 1
Completed	`NCT01091532` - A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.	Phase 1
Completed	`NCT03951402` - Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and Women	Phase 1
Completed	`NCT03882762` - A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol	Phase 1